1108-109 Low hemoglobin is an independent predictor of adverse fatal and nonfatal outcomes in both reduced and preserved systolic function chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity program (CHARM)

McMurray, J. J. et al. (2004) 1108-109 Low hemoglobin is an independent predictor of adverse fatal and nonfatal outcomes in both reduced and preserved systolic function chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity program (CHARM). Journal of the American College of Cardiology, 43(5), A197. (doi:10.1016/s0735-1097(04)90836-4)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: McMurray, J. J., Lang, C. C., Swedberg, K., Östergren, J., Granger, C. B., Michelson, E., Young, J. B., Olofsson, B., Dunlap, M., Yusuf, S., and Pfeffer, M. A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Journal of the American College of Cardiology
Publisher:Elsevier Inc.
ISSN:0735-1097
ISSN (Online):1558-3597

University Staff: Request a correction | Enlighten Editors: Update this record